What Information Does a Supplement Manufacturer Need Before Quoting?

Why incomplete supplement RFQs produce misleading quotes

A request such as “Please quote a magnesium gummy” sounds specific, but it leaves most cost and feasibility decisions unresolved. The active dose may not fit the desired gummy weight. The brand may expect a vegan pectin base, a particular flavor system, a child-resistant closure or a market-specific testing package. Each assumption can change the line, development work, bill of materials and commercial minimum.

The purpose of an initial brief is not to finalize every technical detail. It is to remove the few uncertainties that would cause suppliers to quote fundamentally different manufacturing routes. A range is acceptable for early planning, provided the assumptions are written down and clearly labeled as provisional.

The six inputs required for an initial manufacturing review

1–2. Target market and dosage form determine the route

For the target market, provide more than a country name. State whether the product will be sold through Amazon, retail, practitioners, distributors or a direct-to-consumer website, and list the principal claims under consideration. The manufacturer is not a substitute for the brand’s legal or regulatory adviser, but market context is necessary to plan labels, documents, testing and export support.

For the dosage form, include the target serving and any non-negotiable attributes: vegan, sugar-free, gelatin-free, allergen exclusions, capsule shell preference, powder flavor or liquid delivery format. A formula that fits two capsules may not fit one gummy or one small stick pack. The format should therefore be evaluated against the active load before the brand invests in packaging design.

• State the intended serving size and units per serving.
• Provide a benchmark product or sensory reference where possible.
• Identify ingredients or claims that are mandatory versus optional.
• Clarify whether the format or the formula has priority when capacity is limited.

3. Formula status defines the development scope

A stock or private-label formula can shorten the path when the formula, ingredient sources, specifications and process already exist. A modified formula may appear simple but can require new flavor work, stability assessment or ingredient purchasing. A fully custom formula requires the clearest brief because the first quote may be a budget direction rather than a final production price.

If the formula is not complete, send the desired benefit, required actives, target dose, exclusions, preferred format and benchmark products. If it is complete, send ingredient forms and daily amounts—not only ingredient names. For standardized botanical extracts, branded ingredients or materials with variable assay, specify the potency basis used for the label claim.

4. A realistic quantity range reveals the actual MOQ bottleneck

“As low as possible” does not give a manufacturer enough information to choose a commercial route. A pilot quantity may favor a stock formula and standard packaging, while a larger and repeatable volume can justify custom ingredients, printed components or dedicated tooling.

Ask the supplier to separate the finished-product MOQ from the ingredient and packaging purchase minimums. If the order consumes only part of a material lot, confirm who pays for, owns, stores and eventually disposes of the remainder. A low finished-unit minimum can still create a high total exposure when excess packaging or ingredients are included.

5–6. Packaging and launch timing often control the critical path

For a first review, provide the primary container, count or fill weight, closure, label or print method, secondary box or display requirements and destination case configuration. If the packaging has not been selected, say so. Standard packaging plus a label may be the better validation route when demand is uncertain.

Work backward from the required shelf date. Include time for formula feasibility, sample iterations, specifications, label and artwork review, packaging proofing, long-lead materials, production scheduling, finished-product testing, document release, freight, customs and warehouse receiving. Ask each supplier which approvals must be complete before its quoted lead time begins.

How to make two supplement manufacturing quotes comparable

A useful comparison separates recurring product cost from one-time charges and inventory exposure. The lowest quoted unit price is not necessarily the lowest-risk or lowest-cost project when critical items are excluded.

• Formula and raw-material assay assumptions, including any process or stability overage.
• Finished-product quantity, pack count and packaging specification.
• Included and excluded tests, retest policy and release documents.
• One-time development, sample, tooling, plate, mold or line-setup charges.
• Customer-owned excess ingredients or packaging and any storage charges.
• Incoterm, freight mode, destination, duties and customs responsibility.
• The exact approval event that starts the quoted production lead time.

Copy-and-paste initial project brief

Latitude Nutra uses this information to screen suitable manufacturing routes before requesting detailed commercial responses. Capability, certifications, documentation, MOQ and terms must be confirmed with the specific manufacturing entity selected for the project.

1. 1Target market and sales channel:
2. 2Dosage form and target serving:
3. 3Formula status and required actives:
4. 4First-order quantity range and expected reorder:
5. 5Packaging format, count/fill weight and artwork status:
6. 6Target launch date and any hard approval deadlines:
7. 7Required testing, claims, exclusions or certification expectations:
8. 8Delivery destination and preferred shipping term, if known: